NCT04069637View on ClinicalTrials.gov

Serum and Urine Titanium Levels in Children With Early Onset Scoliosis Treated With Growth-Sparing Instrumentation

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions
Early-Onset Scoliosis Deformity of Spine
Interventions
COMBINATION_PRODUCT

Growth-sparing instrumentation and titanium levels

Patients with growth-sparing instrumentation as treatment for early onset scoliosis, will have their titanium (serum and urine) levels tested, to evaluated if they have elevated titanium levels compared to a control group.

Trial Locations (1)

48109

Michigan Medicine, Ann Arbor

All Listed Sponsors
collaborator

Scoliosis Research Society

OTHER

lead

University of Michigan

OTHER

NCT04069637 - Serum and Urine Titanium Levels in Children With Early Onset Scoliosis Treated With Growth-Sparing Instrumentation | Biotech Hunter | Biotech Hunter